Skip to content

Midatech Pharma US Inc.

Delisted

CIK 919745fmd_1TC8EP8AXSKC6346D99TXGQ9Z0Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2002 to Sep 30, 2015, 30 periods

Income Statement · Annual · Millions · USD
Line itemFY2005FY2006FY2007FY2008FY2009FY2010FY2011FY2012FY2013FY2014
Total revenues–––––––002
Cost of revenue–––––––000
Net interest income––––––––(0)(0)
Gross profit–––––––001
Research and development–––––33320
Selling, general and administrative–––––––6810
Total operating expenses–––––67101111
Operating income–––––(6)(7)(10)(10)(9)
Interest expense–––––0(0)00–
Other non-operating income (expense)–––––00100
Income before taxes–––––(6)(7)(9)(10)(9)
Income tax expense––––––(0)(1)0–
Net income from continuing operations––––––(6)(8)(10)–
Net income(5)(2)(2)(12)(4)(6)(6)(7)(10)(9)
Midatech Pharma US Inc. financial statements · FinancialMD